학술논문
A comprehensive overview of post-stroke depression treatment options.
Document Type
Academic Journal
Author
Raggi A; Unit of Neurology, G.B. Morgagni - L. Pierantoni Civic Hospital, Forlì.; Serretti A; Department of Medicine and Surgery, Kore University of Enna, Enna.; Ferri R; Department of Neurology, Oasi Research Institute - IRCCS, Troina, Italy.
Source
Publisher: Lippincott Williams And Wilkins Country of Publication: England NLM ID: 8609061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5857 (Electronic) Linking ISSN: 02681315 NLM ISO Abbreviation: Int Clin Psychopharmacol Subsets: MEDLINE
Subject
Language
English
Abstract
Nearly one-third of all stroke patients develop depression at any time after a stroke, and its presence is associated with unfavorable outcomes. This narrative review aims to provide a synopsis of possible pharmacological and non-pharmacological treatment modalities for post-stroke depression (PSD). Several studies have demonstrated the efficacy and safety of selective serotonin reuptake inhibitors in treating the symptoms of this clinical condition. The treatment of PSD has been recently enhanced by innovative approaches, such as cognitive-behavioral therapy, virtual reality, telehealth, repetitive transcranial magnetic stimulation, and non-conventional therapies, which might improve depression treatment in stroke survivors. Future high-quality randomized controlled trials are necessary to confirm this hypothesis.
(Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
(Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)